主页 文献库文献详情
PMID: 42433835 已发表 · epublish 英语

Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review.

Annals of medicine and surgery (2012) ·第 88 卷 ·第 7 期 ·2026-07-00

Saleem SM, Nasir SAS, Nida F, Khalid M, Gandhi H, Javaid MH, Roy A

摘要

DNA fix needs BRCA1 and BRCA2. These genes stop bad cell growth. They sit on links 17 and 13. Bad changes in some genes raise the risk of womb cancer. This is true for a type called serous. These faults also boost the chance for womb and breast bad growth. BRCA1 faults lead to more severe womb tumors than BRCA2 faults. Drugs like tamoxifen increase this risk more. More breast trouble adds risk, too. The risk of womb cancer in a lifetime is still small - not quite 3% for BRCA1 folk and just 1 or 2% for BRCA2 folk. Yet, BRCA1 faults might bring worse sorts of womb growth. These have bad cell traits and weak fix tools. Now, rules do not say all BRCA folk must have their wombs removed or get womb checks. They say to talk hard about risks. Think of drug use, weight, and past breast issues. New tools look at many cell parts at once. This helps grasp how BRCA links to bad growth. It lets us pick just the right cures, like PARP drugs. But past studies differ. We need wide, long studies with many groups of folks. This will show the real womb cancer risk. So, BRCA faults do play a small but key part in a bad womb growth type. But they mainly boost breast and egg trouble.

关键词
BRCA1/2 mutations endometrial cancer genetic predisposition precision oncology uterine serous carcinoma
文献信息
期刊
Annals of medicine and surgery (2012)
期刊简称
Ann Med Surg (Lond)
ISSN
2049-0801
发表日期
2026-07-00
语言
英语
国家/地区
England
NLM ID
101616869
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com